US Patent Issued to Shenzhen TargetRx on May 27 for "Aminopyrimidine compound used for inhibiting activity of protein kinase" (Chinese Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,329, issued on May 27, was assigned to Shenzhen TargetRx Inc. (Guangdong, China).

"Aminopyrimidine compound used for inhibiting activity of protein kinase" was invented by Yihan Wang (Guangdong, China) and Huanyin Li (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an aminopyrimidine compound having an inhibitory effect on the activity of protein kinase as well as the preparation and use thereof. Specifically, disclosed by the present invention is an aminopyrimidine compound represented by formula (I), or a pharmaceutically acceptable salt, stereoisomer, solvate or hydrate thereof, as well as a pharma...